- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03338517
Helium-Neon Laser Therapy Versus Infrared Laser Therapy in Treating Patients With Diabetic Foot Ulcer
A Randomized Controlled Trial Comparing Helium-Neon Laser Therapy and Infrared Laser Therapy in Patients With Diabetic Foot Ulcer
Background: Diabetic patients are frequently showed with foot ulceration as a common complication which increases to 20% in admission. Low-level laser therapy is used to control foot ulcer, but there is very limited data to compare the effects of Helium-Neon Laser therapy (HNLT) and Infrared Laser therapy (ILT) on diabetic foot ulcer.
Objectives: This study aimed to compare the effects of (HNLT) and (ILT) on diabetic foot ulcer.
Methods: Sixty-five patients with diabetic foot ulcer (51 males and 14 females) aged 50-60years. The participants were classified randomly to two groups, Helium-Neon Laser therapy (HNLT) and Infrared Laser therapy (ILT) groups. HNLT group received medical treatment with Helium-Neon Laser therapy and ILT group received medical treatment with Infrared Laser therapy for 8 weeks. Ulcer surface area was assessed using a sheet of cellophane paper at the beginning of the study, after four weeks, and after eight weeks at the end of the study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study was carried out after obtaining ethical approval from the Department of surgery, Cairo University Hospitals, Egypt. Patients with varying stages of diabetic foot ulcers in the hospital were screened and included in the study. 65 diabetic patients with Grade I and II ulcers were selected according to Wagner classification, ages ranged between 50 to 60 years of age, BMI of 30 free from any metabolic-related medical conditions such as nephropathy, cardiomyopathy, recent myocardial infarction and pulmonary problems. Patients were randomized into two groups; Group (I) who received medical treatment with Helium-Neon Laser therapy (HNLT), (ASA Medical laser device (manufactured by ASA Terza- Via Alessandro, Italy) and Group (II) who received medical treatment with Infrared Laser therapy (ILT), (PHYACTION 792/796 manufactured in The Netherlands by Uniphy BV). The nature of the therapy was described and explained to the patient. A written informed consent was obtained prior to implementation of the study. Patients were subjected to detailed medical examination. Glucosylated Homoglobin (HbA1c) was obtained for patient screening.
Outcome measures Ulcer surface area was calculated by getting the impression of the ulcer floor using a sheet of cellophane paper. The imprint of the ulcer floor is transferred to graphing paper where ulcer size was plotted and diameter was recorded. Ulcer size was measured at the beginning of the study, after 4 weeks, and after 8 weeks at the end of study.
The position of patient was a comfortable position with disclosure of the affected foot. Transparent plastic films were double sterilized and directly placed flat and connected to the skin at the ulcer area with nullifing any motion or misrepresentation of the affected foot. The margins of the ulcer were followed by the same investigator to set up the measurements reliability16.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with Grade I and II ulcers were selected according to Wagner classification ages ranged between 50 to 60 years of age, BMI of 30
Exclusion Criteria:
- nephropathy, cardiomyopathy, recent myocardial infarction and pulmonary problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
No intervention
|
|
Active Comparator: Study group
Helium Neon Laser
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ulcer surface area
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Sayed A A Tantawy, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/012/001255
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laser
-
Chinese University of Hong KongCompletedAwake Laser | Microlaryngeal Surgery | Benign Laryngeal Lesion | Transnasal Laser SurgeryHong Kong
-
Huazhong University of Science and TechnologyCompleted
-
Goldman, Butterwick, Fitzpatrick and GroffCompletedExposure LaserUnited States
-
National Taiwan University HospitalBRIDGECON CO,.LTD.RecruitingLaser | PeriorbitalTaiwan
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Kaohsiung Veterans General Hospital.UnknownEndometrium | LaserTaiwan
-
Cairo UniversityUnknownStriae Distensae | Fractional CO2 Laser | Striae; Albicantes | Striae Alba | Nd-YAG Laser | High Frequency Skin Ultrasound | Short Pulsed Nd-YAG | Carbon Dioxide Laser | Neodymium-Doped Yttrium Aluminum Garnet LaserEgypt
-
Alma LasersActive, not recruitingLaser Assisted LiposuctionUnited States
-
Lumenis Be Ltd.Completed
-
Cutera Inc.WithdrawnLaser Tattoo RemovalCanada
Clinical Trials on Helium Neon Laser
-
University of Massachusetts, WorcesterWithdrawn
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Withdrawn
-
University of AlbertaCompletedLung Diseases | Chronic Obstructive Pulmonary Disease | Emphysema | COPD | Bronchitis, ChronicCanada
-
University of PennsylvaniaTerminatedChronic Obstructive Pulmonary Disease (COPD)United States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedPulmonary HypertensionUnited Kingdom
-
University of SaskatchewanNova Scotia Health AuthorityCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedHealthy VolunteersUnited Kingdom
-
Northwell HealthStaten Island University HospitalCompletedObstructive Sleep Apnea SyndromeUnited States
-
Western University, CanadaRecruiting
-
University of Wisconsin, MadisonWashington University School of Medicine; National Heart, Lung, and Blood Institute... and other collaboratorsCompleted